Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9400179 | 0.79 | CHRM2 (0.33) | ALDH1A1TDP1 | |
| SCHEMBL23252699 | 0.78 | FDPS (0.34) | ALDH1A1LMNAHSD17B10FDPS | |
| SCHEMBL19458601 | 0.78 | LMNA (0.42) | ALDH1A1LMNAHSD17B10FDPSTDP1 | |
| SCHEMBL23663504 | 0.73 | ALDH1A1 (0.38) | ALDH1A1LMNAHSD17B10 | |
| SCHEMBL17710552 | 0.72 | — | — | |
| SCHEMBL12326370 | 0.70 | ALDH1A1 (0.34) | ALDH1A1LMNAHSD17B10FDPSTDP1 | |
| SCHEMBL9930151 | 0.67 | FDPS (0.31) | ALDH1A1LMNAHSD17B10FDPS | |
| SCHEMBL6544006 | 0.67 | — | — | |
| SCHEMBL22081708 | 0.67 | LMNA (0.41) | ALDH1A1LMNAHSD17B10FDPSTDP1 | |
| SCHEMBL14479855 | 0.67 | ALDH1A1 (0.32) | ALDH1A1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11214578-B2 | Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof | NORTHEASTERN UNIVERSITY (US) | 2022-01-04 | — | — | US | disclosed |
| US-20200148696-A1 | Urea/Carbamates FAAH MAGL Or Dual FAAH/MAGL Inhibitors And Uses Thereof | NORTHEASTERN UNIVERSITY | 2020-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11214578-B2 | Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof | FAAH, FAAH2, MGLL | ALDH1A1 687/4885LMNA 2835/4885HSD17B10 907/4885 |
| US-20200148696-A1 | Urea/Carbamates FAAH MAGL Or Dual FAAH/MAGL Inhibitors And Uses Thereof | FAAH, MGLL, FAAH2 | ALDH1A1 2074/4885LMNA 2315/4885HSD17B10 1734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.